Tapemark has acquired the iontoPatch business from Travanti Pharma, Inc., a wholly owned subsidiary of Teikoku Pharma USA, Inc. The iontoPatch, product line along with a suite of iontophoretic technology for use in medical devices and cosmetics, will be marketed under the Travanti Medical name.

Andy Rensink, Tapemark's president, remarked, “Tapemark is excited to add the iontoPatch technology to our existing delivery platforms, SNAP and SoluStrip, both of which support custom manufacturing solutions for a broad range of pharmaceutical, medical device and consumer products customers around the globe.”

The iontoPatch product line is currently utilized extensively in the physical therapy market. Robert Arnold, general manager of the newly formed Travanti Medical unit, said, “Combining product design, manufacturing and regulatory strategy in one entity allows us to more proactively and efficiently address performance enhancements strongly desired by our customers.”